Ausgabe 6/2020
Inhalt (32 Artikel)
Ruxolitinib-based combinations in the treatment of myelofibrosis: worth looking forward to
Yujin Li, Shirong Zhu, Weiyi Liu, Jing Ming, Xueying Wang, Xiaomei Hu
Management of myelofibrosis after ruxolitinib failure
Claire N Harrison, Nicolaas Schaap, Ruben A Mesa
How to treat myelodysplastic syndrome with clinical features resembling Behçet syndrome: a case-based systematic review
Umut Yilmaz, Muhlis Cem Ar, Sinem Nihal Esatoglu, Isil Bavunoglu, Yusuf Ziya Erzin, Ali Ibrahim Hatemi, Suleyman Yildirim, Gülen Hatemi, Aykut Ferhat Celik
Mechanism of thrombocytopenia in COVID-19 patients
Panyang Xu, Qi Zhou, Jiancheng Xu
Red blood cell consumption in a large cohort of patients with thalassaemia: a retrospective analysis of main predictors
Paolo Ricchi, Antonella Meloni, Silvia Costantini, Anna Spasiano, Patrizia Cinque, Biagio Gargiulo, Alessia Pepe, Aldo Filosa
Outcomes related to intravenous fluid administration in sickle cell patients during vaso-occlusive crisis
Daria Gaut, Jennifer Jones, Caroline Chen, Sanaz Ghafouri, Mei Leng, Roswell Quinn
Sickle cell anemia in the state of Maranhão: a haplotype study
Ademilton Costa Alves, Verônica Avena Lisboa da Silva, Alexandro Dos Santos, Mariana Barreto Serra, Felipe Albuquerque Marques, Sônia Maria Pereira Cruz, Wermerson Assunção Barroso, Raimundo Antônio Gomes de Oliveira
Immunodeficiency risk score for prediction of mortality by parainfluenza virus infection in patients with hematologic malignancy
Jeongsoo Lee, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Sang-Oh Lee, Sang-Ho Choi, Yang Soo Kim, Jun Hee Woo, Eun-Ji Choi, Han-Seung Park, Jung-Hee Lee, Je-Hwan Lee, Kyoo-Hyung Lee, Sung-Han Kim
Relationship between molecular response and quality of life with bosutinib or imatinib for chronic myeloid leukemia
Tim H. Brümmendorf, Carlo Gambacorti-Passerini, Andrew G. Bushmakin, Joseph C. Cappelleri, Andrea Viqueira, Arlene Reisman, Susanne Isfort, Carla Mamolo
Clinical characteristics and outcomes of oligosecretory and non-secretory multiple myeloma
Magdalini Migkou, Irit Avivi, Maria Gavriatopoulou, Yael C. Cohen, Despina Fotiou, Nikolaos Kanellias, Dimitrios Ziogas, Evangelos Eleutherakis-Papaiakovou, Evangelos Terpos, Maria Roussou, Efstathios Kastritis, Meletios A. Dimopoulos
Long PFS of more than 7 years is achieved in 9% of myeloma patients in the era of conventional chemotherapy and of first-generation novel anti-myeloma agents: a single-center experience over 20-year period
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Roussou, Nikolaos Kanellias, Despina Fotiou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, Efstathios Kastritis, Meletios A. Dimopoulos
Risk of kidney toxicity with carfilzomib in multiple myeloma: a meta-analysis of randomized controlled trials
Somedeb Ball, Tapas Ranjan Behera, Faiz Anwer, Rajshekhar Chakraborty
Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study
Yael C. Cohen, Hila Magen, Noa Lavi, Moshe E. Gatt, Evgeni Chubar, Nethanel Horowitz, Natalia Kreiniz, Tamar Tadmor, Svetlana Trestman, Roy Vitkon, Ory Rouvio, Olga Shvetz, Adir Shaulov, Tomer Ziv-Baran, Irit Avivi
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis
Sang Eun Yoon, Seok Jin Kim, Dok Hyun Yoon, Youngil Koh, Yeung-Chul Mun, Young Rok Do, Yoon Seok Choi, Deok Hwan Yang, Min Kyoung Kim, Gyeong-Won Lee, Cheolwon Suh, Young Hyeh Ko, Won Seog Kim
Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas
Joon Young Hur, Yeon Jeong Kim, Sang Eun Yoon, Dae-Soon Son, Woong-Yang Park, Seok Jin Kim, Donghyun Park, Won Seog Kim
Abnormal pretreatment coagulation factor levels correlate with poor prognosis in patients with early-stage extranodal nasal-type natural/killer T cell lymphoma
Yue Chai, Fei Qi, Bo Chen, Lin Gui, Jianliang Yang, Shunan Qi, Yongwen Song, Yexiong Li, Yuce Wei, Mei Dong
Upfront autologous stem cell transplantation for untreated diffuse large B cell lymphoma patients in rituximab era: a systematic review and meta-analysis
Shu-Yun Ma, Xiao-Peng Tian, Jun Cai, Guang-Zheng Zhong, Xu Chen, Hui-Qiang Huang, Tong-Yu Lin, Zhi-Ming Li, Qing-Qing Cai
Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in elderly HL: a two-center experience in 123 patients
Domenico Albano, Angelica Mazzoletti, Marianna Spallino, Cristina Muzi, Vittorio Ruggiero Zilioli, Chiara Pagani, Alessandra Tucci, Claudio Rossetti, Raffaele Giubbini, Francesco Bertagna
Pegfilgrastim improves the outcomes of mobilization and engraftment in autologous hematopoietic stem cell transplantation for the treatment of multiple myeloma
Xiao Ding, Wenyang Huang, Yi Peng, Hongqiong Fan, Yingqiao Zhu, Xuelian Liu, Yanping Yang, Qiang Guo, Lugui Qiu, Yun Dai, Dehui Zou, Fengyan Jin
Absence of influence of peripheral blood CD34+ and CD3+ graft cell counts on outcomes after reduced-intensity conditioning transplantation using post-transplant cyclophosphamide
Alice Garnier, Thierry Guillaume, Pierre Peterlin, Amandine Le Bourgeois, Béatrice Mahé, Viviane Dubruille, Nicolas Blin, Cyrille Touzeau, Thomas Gastinne, Anne Lok, Benoit Tessoulin, Alix Duquesne, Marion Eveillard, Steven Le Gouill, Philippe Moreau, Marie C. Béné, Patrice Chevallier
Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia conducted in Japan during the past quarter century
Masamitsu Yanada, Akiyoshi Takami, Satoshi Yamasaki, Yasuyuki Arai, Takaaki Konuma, Naoyuki Uchida, Yuho Najima, Takahiro Fukuda, Masatsugu Tanaka, Yukiyasu Ozawa, Kazuhiro Ikegame, Minoko Takanashi, Tatsuo Ichinohe, Shinichiro Okamoto, Yoshiko Atsuta, Shingo Yano
The management of gynecological complications in long-term survivors after allogeneic hematopoietic cell transplantation—a single-center real-life experience
Łukasz Klasa, Alicja Sadowska-Klasa, Agnieszka Piekarska, Dariusz Wydra, Jan Maciej Zaucha
Impact of blood pressure early after allogeneic hematopoietic cell transplantation on clinical outcomes
Masaharu Tamaki, Hideki Nakasone, Shunto Kawamura, Junko Takeshita, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Ayumi Gomyo, Aki Tanihara, Machiko Kusuda, Yu Akahoshi, Koji Kawamura, Shun-ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation
Ivan Pasic, Jeffrey H. Lipton, Dennis D. Kim, Auro Viswabandya, Rajat Kumar, Wilson Lam, Arjun D. Law, Jonas Mattsson, Fotios V. Michelis
A case of idiopathic multicentric Castleman disease presenting with diffuse lung cysts: how to evaluate treatment response?
Wanlu Ma, Jian Li, Lu Zhang
The concomitance of lymphoma and breast carcinoma in the bone
Francesco Autore, Idanna Innocenti, Alberto Fresa, Ambra Paolini, Federica Sora, Simona Sica, Gina Zini, Luca Laurenti
Treatment strategy in a patient showing borderline features between plasmablastic lymphoma and plasmablastic myeloma harboring a 17p deletion
Kyoko Yoshihara, Satoshi Yoshihara, Ikuo Matsuda, Takehito Imado, Shohei Matsuo, Masaya Okada, Yoshifumi Shimizu, Seiichi Hirota, Yoshihiro Fujimori
Subcutaneous marginal zone lymphoma: an unusual lipoma-like presentation
Magda Zanelli, Maurizio Zizzo, Francesca Sanguedolce, Alessandra Soriano, Giovanni Martino, Valerio Annessi, Stefano Ascani
Hypomethylating agents super-responders: challenging the dogma of long-term remission for acute myeloid leukemia
Joseph E. Maakaron, Michael P. Ozga, Gabriel N. Mannis, Will Pulley, Matthew C. Foster, Joshua F. Zeidner, Alice S. Mims
Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
Charu Gupta, Stefan Kaulfuss, Kerstin Görlich, Basem Othman, Anuhar Chaturvedi, Michael Heuser
Signals of Th2 immune response from COVID-19 patients requiring intensive care
Luca Roncati, Vincenzo Nasillo, Beatrice Lusenti, Giovanni Riva